The MarketWatch News Department was not involved in the creation of this content. Dr. Alexander Rivkin, a global pioneer in Non-Surgical Rhinoplasty, contributes to an award winning international ...

SAN DIEGO -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today the first patient has been dosed in a closed loop control ("artificial pancreas") clinical study involving Halozyme's ...

Huonslab files BLA for HYDIZYME™, targeting MFDS approval in 2026 for its recombinant human hyaluronidase using HyDIFFUZE™.

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products, like its hyaluronidase. Under the Inflation Reduction Act, the ...

SAN DIEGO, Dec. 21, 2012 /PRNewswire via COMTEX/ -- Halozyme Therapeutics, Inc. HALO -2.65% announced today that it has entered into a worldwide Collaboration and License Agreement with Pfizer Inc.

The COVID-19 pandemic had a significant impact on the hyaluronidase market. For instance, a 2021 article by the British Association of Aesthetic Plastic Surgeons (BAAPS) stated that there was a 27% ...

Lower concentrations of hyaluronidase were as effective as higher concentrations at degrading hyaluronic acid fillers, according to study results published in Dermatologic Surgery. Margit L. W. Juhász ...